Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Journal of Chemical Information and Modeling|December 19, 2012
3D molecular descriptors important for clinical successDavid C Kombo, Kartik Tallapragada, Rachit Jain, et al.
Pharmaceutical Research|March 22, 2007
Lysosomes contribute to anomalous pharmacokinetic behavior of melanocortin-4 receptor agonistsYuping Gong, Zhiyang Zhao, Donavon J McConn, et al.
Bioorganic & Medicinal Chemistry Letters|January 4, 2011
Tetrahydroquinoline derivatives as opioid receptor antagonistsCunyu Zhang, Susan M Westaway, Jason D Speake, et al.
The British Journal of Surgery|May 6, 2016
Multicentre study of short-course radiotherapy and transanal endoscopic microsurgery for early rectal cancerC J Smart, S Korsgen, J Hill, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2003
2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compoundsJason D Speake, Frank Navas, Michael J Bishop, et al.
Journal of Medicinal Chemistry|May 17, 2002
2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analoguesStephen J Hodson, Michael J Bishop, Jason D Speake, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2002
Alpha(1)-adrenoceptor activation: a comparison of 4-(anilinomethyl)imidazoles and 4-(phenoxymethyl)imidazoles to related 2-imidazolinesStephen J Hodson, Eric C Bigham, Deanna T Garrison, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2002
2-(anilinomethyl)imidazolines as alpha1A adrenergic receptor agonists: 2'-heteroaryl and 2'-oxime ether seriesFrank Navas, Michael J Bishop, Deanna T Garrison, et al.
Pageof 3